Immune health: FDA Approvals, Recalls, 510(k) Clearances and Side Effect Reports

What the US Food and Drug Administration has cleared, approved and recalled on this topic, and the side effects people report.

New drug approvals

1 new medicines approved (since 1 Jan 2023). Medicines with a new active ingredient that the FDA approved, whose label lists a use on this topic.

At the source
  • Wayrilz (rilzabrutinib)

    Approved for: WAYRILZ is indicated for the treatment of adult patients with persistent or chronic immune thrombocytopenia (ITP) who have had an insufficient response to a previous treatment. WA…

    NDA219685

Source: openFDA, Novel drug approvals (new molecular entities and new biologics), since 1 Jan 2023. Retrieved 12 Nov 2026.

Drug recalls

1 recalls (since 1 Jan 2023). Recalls of medicines for this topic, newest first.

At the source

Source: openFDA, Drug recall enforcement reports, since 1 Jan 2023. Retrieved 12 Nov 2026.

Device recalls

2 recalls (since 1 Jan 2023). Recalls of medical devices for this topic, newest first.

At the source
  • Multi-Analyte Controls, All Kinds (Assayed)

    Reason: Vial-to-vial variability in MAS Omni"IMMUNE PRO Liquid Assayed Integrated Immunoassay Control, Level 1, Lot OPRO29061A results in low Parathyroid Hormone (PTH) recovery, which may lead to a delay in…

    Z-0159-2027
  • Transferrin, Rhodamine, Antigen, Antiserum, Control

    Reason: The firm has identified that the Transferrin reagent does not meet the Instructions for Use (IFU) reagent on-board stability claims, which may cause control failures and/or erroneous patient samples…

    Z-0309-2024

Source: openFDA, Medical device recalls, since 1 Jan 2023. Retrieved 12 Nov 2026.

Side effects people report

15,052 side effect reports (reports received since 1 Jan 2023). The reactions named most often in reports about medicines used for this topic.

At the source
  1. 1Platelet count decreased1,771 reports
  2. 2Diarrhoea1,012 reports
  3. 3Headache728 reports
  4. 4Fatigue661 reports
  5. 5Hereditary angioedema651 reports
  6. 6Nausea537 reports
  7. 7Platelet count increased496 reports
  8. 8Pneumonia411 reports
  9. 9Immune thrombocytopenia408 reports
  10. 10Weight increased397 reports

Anyone can send a report. A report does not prove that the medicine caused the reaction, and the counts do not show how often it happens.

Source: openFDA, FDA Adverse Event Reporting System (FAERS), reports by reaction, reports received since 1 Jan 2023. Retrieved 12 Nov 2026.

FDA approvals and recalls on related topics

All topics

Acuitas market sizes and forecasts are only in our full reports. How we use public data.